These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30188931)

  • 21. Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.
    Ackermann B; Kröber S; Torres-Benito L; Borgmann A; Peters M; Hosseini Barkooie SM; Tejero R; Jakubik M; Schreml J; Milbradt J; Wunderlich TF; Riessland M; Tabares L; Wirth B
    Hum Mol Genet; 2013 Apr; 22(7):1328-47. PubMed ID: 23263861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
    Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ
    Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term
    Muiños-Bühl A; Rombo R; Ling KK; Zilio E; Rigo F; Bennett CF; Wirth B
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nusinersen ameliorates motor function and prevents motoneuron Cajal body disassembly and abnormal poly(A) RNA distribution in a SMA mouse model.
    Berciano MT; Puente-Bedia A; Medina-Samamé A; Rodríguez-Rey JC; Calderó J; Lafarga M; Tapia O
    Sci Rep; 2020 Jul; 10(1):10738. PubMed ID: 32612161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutics development for spinal muscular atrophy.
    Sumner CJ
    NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
    d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
    Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings.
    Bernal S; Also-Rallo E; Martínez-Hernández R; Alías L; Rodríguez-Alvarez FJ; Millán JM; Hernández-Chico C; Baiget M; Tizzano EF
    Neuromuscul Disord; 2011 Jun; 21(6):413-9. PubMed ID: 21546251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival motor neuron protein regulates oxidative stress and inflammatory response in microglia of the spinal cord in spinal muscular atrophy.
    Ando S; Osanai D; Takahashi K; Nakamura S; Shimazawa M; Hara H
    J Pharmacol Sci; 2020 Dec; 144(4):204-211. PubMed ID: 33070839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
    Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
    Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.
    Gavrilina TO; McGovern VL; Workman E; Crawford TO; Gogliotti RG; DiDonato CJ; Monani UR; Morris GE; Burghes AH
    Hum Mol Genet; 2008 Apr; 17(8):1063-75. PubMed ID: 18178576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMN, profilin IIa and plastin 3: a link between the deregulation of actin dynamics and SMA pathogenesis.
    Bowerman M; Anderson CL; Beauvais A; Boyl PP; Witke W; Kothary R
    Mol Cell Neurosci; 2009 Sep; 42(1):66-74. PubMed ID: 19497369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic ∆7SMA mice.
    Kray KM; McGovern VL; Chugh D; Arnold WD; Burghes AHM
    Neurobiol Dis; 2021 Nov; 159():105488. PubMed ID: 34425216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
    Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal and tissue-specific variability of SMN protein levels in mouse models of spinal muscular atrophy.
    Groen EJN; Perenthaler E; Courtney NL; Jordan CY; Shorrock HK; van der Hoorn D; Huang YT; Murray LM; Viero G; Gillingwater TH
    Hum Mol Genet; 2018 Aug; 27(16):2851-2862. PubMed ID: 29790918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol.
    Tiziano FD; Lomastro R; Abiusi E; Pasanisi MB; Di Pietro L; Fiori S; Baranello G; Angelini C; Sorarù G; Gaiani A; Mongini T; Vercelli L; Mercuri E; Vasco G; Pane M; Vita G; Vita G; Messina S; Petillo R; Passamano L; Politano L; Campanella A; Mantegazza R; Morandi L
    J Med Genet; 2019 May; 56(5):293-300. PubMed ID: 30593463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse.
    Porensky PN; Mitrpant C; McGovern VL; Bevan AK; Foust KD; Kaspar BK; Wilton SD; Burghes AH
    Hum Mol Genet; 2012 Apr; 21(7):1625-38. PubMed ID: 22186025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological impact of SMN2 mis-splicing in adult SMA mice.
    Sahashi K; Ling KK; Hua Y; Wilkinson JE; Nomakuchi T; Rigo F; Hung G; Xu D; Jiang YP; Lin RZ; Ko CP; Bennett CF; Krainer AR
    EMBO Mol Med; 2013 Oct; 5(10):1586-601. PubMed ID: 24014320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.
    Singh NN; Lee BM; DiDonato CJ; Singh RN
    Future Med Chem; 2015; 7(13):1793-808. PubMed ID: 26381381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic strategies for spinal muscular atrophy: SMN and beyond.
    Bowerman M; Becker CG; Yáñez-Muñoz RJ; Ning K; Wood MJA; Gillingwater TH; Talbot K;
    Dis Model Mech; 2017 Aug; 10(8):943-954. PubMed ID: 28768735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of PLS3 expression with disease severity in children with spinal muscular atrophy.
    Yanyan C; Yujin Q; Jinli B; Yuwei J; Hong W; Fang S
    J Hum Genet; 2014 Jan; 59(1):24-7. PubMed ID: 24172247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.